increased substantially which can outweigh lower visit number. The increase of revenue per visit was the result of more surgeries operated particularly heart surgeries and minimal invasive surgeries. All
25.7 MB or representing an increase of 88.7% from Q4-2016 due to the fact that during the first half of 2017 the Company had paid repayment of long-term loans which was due. Shareholders' Equity As of
Increase (Decrease) Percentage Asset 1,757.85 1,573.51 184.34 11.72 Liabilities 830.88 686.91 143.97 20.96 Shareholders 'Equity 926.97 886.60 40.37 4.55 The cause of the company's financial situation changed
operating results of the consolidated financial statement for the year period ended December 31, 2018, resulted in increase in net profit of Baht 41.11 million or 43.09% from the corresponding period of the
by THB 53mn or 3.5%. This was attributed to an increase unappropriated retained earnings of THB 53mn. As of 31 March 2018, total equity included with equity attributable to owners of the Company of THB
”) reported consolidated operating revenue of THB 376 million in Q2/2024 and THB 716 million in 1H/2024, increased by 26% from Q2/2023 and 27% from 1H/2023, respectively. The increase in revenue was mainly due
at 31 December 2016 of Baht 4,240 million. It is mainly due to the increase in short-term loans from financial institutions. Shareholders’ equity As at 30 September 2017, the Group’s shareholders
attributable to equity holders of the Company in the amount of Baht 3,123 Million representing an increase from the previous year by Baht 517 Million or 19.8 percent. The Company had total revenue of Baht 15,393
decrease from 16,525 THB/ton to 12,151 THB/ton or decreased by 27%. Although the Company recorded sales volume increase from 196,221 tons to 355,988 tons or increased by 81%. Other incomes A reason of
Baht) Q1 ended 31 March % changes 2020 2019 Increase (decrease) Sales 123,224 169,361 (27.24) Total revenues 135,209 181,787 (25.62) Cost of sales 114,031 166,753 (31.62) Selling and administrative